Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Crosstalk between the redox signalling and the detoxification: GSTs under redox control
Non-invasive mesotherapy for localized fat reduction
Stojcheva, E
To learn more about this report, Glucagon Like Peptide 1 Analogs Market Insights, By Brand - Saxenda commands the highest share of the market driven by its targeted weight management positioning and brand recognition Saxenda is expected to lead the glucagon like peptide 1 analogs market by brand largely because of its established presence as an effective weight management therapy for obesity and overweight adults with share of 21.1% in 2026
US$ 29.25
US$ 22.18
US$ 26.42
US$ 22.62
US$ 26.22
US$ 26.27
US$ 21.67
